I'm in on the placement. The next 6 months will be a cracker !
AventaCell Biomedical Corp have invested $1.5 mil of the $3 million.
"AventaCell is a US-based life sciences company developing novel human-derived products for
use in cell culture and tissue regeneration. The company is the global leader in cell culture
supplements manufactured using Cambium Bio's proprietary human platelet technology under
an existing license agreement. "
Cheapest Phase 3 biotech on the ASX by a long way. Now funded to start the trial.
Ann: Cambium Bio Successfully Closes A$3.0M Financing Round, page-2
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
32.0¢ |
Change
0.055(20.8%) |
Mkt cap ! $5.850M | |||
| Open | High | Low | Value | Volume |
| 28.5¢ | 32.0¢ | 28.5¢ | $14.12K | 47.96K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 56261 | 29.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.0¢ | 3987 | 2 |
View Market Depth
| Last trade - 15.33pm 28/07/2025 (20 minute delay) ? |
| CMB (ASX) Chart |